Copyright
©The Author(s) 2021.
World J Clin Cases. Dec 26, 2021; 9(36): 11173-11182
Published online Dec 26, 2021. doi: 10.12998/wjcc.v9.i36.11173
Published online Dec 26, 2021. doi: 10.12998/wjcc.v9.i36.11173
Items | β | OR (95%CI) | P value |
Gender (male) | -0.647 | 0.524 (0.203, 1.354) | 0.182 |
Age (yr) | 0.007 | 1.007 (0.965,1.050) | 0.762 |
Distant metastasis (n) | 1.193 | 3.296 (1.112, 9.770) | 0.031 |
History of diuretics (n) | -1.212 | 0.298 (0.090,0.988) | 0.048 |
TSH (mIU/L) | -0.009 | 0.991 (0.980,1.002) | 0.101 |
Urinary iodine (µg/L) | -0.011 | 0.989 (0.98,0.998) | 0.075 |
eGFR (mL/min m2) | -0.032 | 0.969 (0.934,1.005) | 0.09 |
Pre-operation Na (mmol/L) | -0.271 | 0.763 (0.627, 0.928) | 0.007 |
Blood urea nitrogen (mmol/L) | 0.420 | 1.521 (1.094, 2.115) | 0.013 |
- Citation: Cao JJ, Yun CH, Xiao J, Liu Y, Wei W, Zhang W. Analysis of the incidence and influencing factors of hyponatremia before 131I treatment of differentiated thyroid carcinoma. World J Clin Cases 2021; 9(36): 11173-11182
- URL: https://www.wjgnet.com/2307-8960/full/v9/i36/11173.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i36.11173